Search for: "DOC Commissioner" Results 341 - 360 of 477
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 May 2011, 1:21 pm by admin
  If this is the case, then the Competition Tribunal may, on application by the Commissioner of Competition, order that the merger not proceed (in whole or in part). [read post]
8 Feb 2016, 9:37 am by Dennis Crouch
§ 6(b). [6] Following professor John Duffy’s 2007 article on-point, these roles have been tightened-up. http://patentlyo.com/media/docs/2011/10/Duffy.BPAI.pdf. [read post]
9 Apr 2017, 8:28 pm by Caesar and Napoli, P.C.
Nisha Agarwal, the commissioner of New York City’s Office of Immigration Affairs, recently reminded the public that, “ICE does have the ability to arrest people in public. [read post]
5 Feb 2011, 5:15 pm by INFORRM
The exemption claims were upheld, but the Information Commissioner applied the public interest override to order release of the documents to which it applied. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells… [read post]
6 Jul 2013, 12:39 pm by Florian Mueller
Commissioner Pinkert's dissent is the only silver lining in a ruling of which I've obtained the final, public redacted version and which is actually much worse than even the worst German FRAND-related ruling I saw. [read post]
20 Mar 2009, 9:00 am
Bank of America Technology & Operations, Inc (IP Law Blog)   US General – Lawsuits and strategic steps Clear Channel Communications – Clear Channel, Live Nation cut from business model antitrust suit (Law360)   US Patent Reform Patent Reform Act 2009 – Interlocutory claim construction appeals create a whole new patent backlog (Promote the Progress) Patent Reform Act 2009: more on damages (Patently-O) Patent Reform Act 2009: Rooklidge says… [read post]
5 Jul 2023, 4:37 pm by INFORRM
Meanwhile, he commenced proceedings against various defendants, including the Garda Commissioner and the Irish Independent, for damages for invasion of privacy. [read post]
14 Feb 2011, 3:29 am by Marie Louise
495/09 Nokia Corporation v Her Majesty’s Commissioners of Revenue and Customs (IPKat) A touch of class: Latest news of IP TRANSLATOR (IPKat) Beware the ‘own name’ defense – AG opinion in Edwin Co (Property, intangible) General Court: likelihood of confusion for Oyster and Oystra (Class 46) OHIM Board of Appeal: nasty decision about the comparison of goods – no likelihood of confusion between MALONE and MALOTE (Class 46) Can a European divisional poison its… [read post]
23 Mar 2012, 1:30 am by Monique Altheim
# #eudpconf re: improvements Safe Harbor: O'Neill(DoC): more resources; Albrecht (MEP): individual redress;Smith(ICO):more audits; # Does Webcam Spying Really Deserve A Ten-Year Prison Sentence? [read post]
28 Feb 2019, 5:52 am by Florian Mueller
But ultimately the question of whether Article 13 will or will not be passed into law is a matter of numbers, so I wanted to analyze the Pledge2019 results and generally take a closer look at the vote the Parliament held in September 2018 on Axel Voss MEP's negotiating mandate.A spreadsheet with key voting results from September 2018 is available on Google Docs. [read post]
11 Aug 2014, 8:33 pm
Professor Schabas has worked as a consultant on capital punishment for the United Nations Office of Drugs and Crime, and drafted the 2010 report of the Secretary-General on the status of the death penalty (UN Doc. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
29 Nov 2010, 12:23 am by Kelly
Hydro-Quebec (Green Patent Blog) (Patent Prospector) District Court Colombia: Stryker’s challenge of USPTO ruling in bone screw interference struck down: Stryker Spine v Biedermann Motech (Patent Docs) District Court S D Florida: Intent to deceive element of false marking claim cannot be inferred from failure to pay maintenance fees and later revision of product packaging: Herengracht Group LLC v. [read post]
10 Nov 2007, 10:07 pm
[www.oranous.com][www.oranous.com]No. 07-5439 IN THE Supreme Court of the United StatesRALPH BAZE, et al,Petitioners, v.JOHN D. [read post]
12 Apr 2007, 2:01 pm
Doc Rivers' lineups usually feature the typical balance of rebounders, ballhandlers and shooters. [read post]
13 Oct 2008, 12:12 pm
(RelatIP) New procedure at the Brazilian Patent Office for the application of article 32 of the Industrial Property Law (IP tango)   Canada 30 more candidates add their support for the copyright pledge (Michael Geist) CBC on copyright pledge (Michael Geist) Copyright pledge gains momentum - Green Party and New Democrats Party (NDP) candidates on board (Michael Geist) Conservative Party platform on copyright (EXCESS COPYRIGHT) (Michael Geist) Copyright in local election debates (Michael… [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb),US: Dr Robert Shapiro discusses follow-on biologics report: (Patent Docs),US: New report identifies $387 billion in savings from generic biologics: (Holman's Biotech IP Blog),US: Can approval of biogenerics really save money? [read post]
29 Feb 2008, 8:00 am
– Teva’s opposition proceedings regarding IL 130424 to Pfizer: (IP Factor), Thailand: Thai chief drug price negotiator removed from post: (GenericsWeb), Thailand: Compulsory licences cannot be revoked: (Generic Pharmaceuticals & IP), (more from Generic Pharmaceuticals & IP), UK: Court of Appeal for England and Wales hands down decision in Boehringer Ingelheim KG and Boehringer Ingelheim Pharma KG v Swingward Limited relating to repackaging and de-branding of… [read post]